The best indicator for Vertiv (VRT)
We backtested 20 indicators across daily, weekly and hourly charts on real Vertiv (VRT) history. Here's what actually worked — risk-adjusted, out-of-sample, with costs.
Donchian Midline
On the weekly chart, this is the strongest risk-adjusted edge we found for Vertiv (VRT) over ~7.9 years — beating buy-and-hold by 2.2% CAGR.
The winner on each chart
Every indicator, ranked
Ranked by Sharpe (risk-adjusted return). Hypothetical, fees included.
| # | Indicator | TF | CAGR | Sharpe | Max DD | Win | Trades | vs B&H |
|---|---|---|---|---|---|---|---|---|
| 1 | Donchian Midline ✓ | Weekly | 56.3% | 1.33 | -43.5% | 66.7% | 15 | 2.2% |
| 2 | Donchian Breakout ✓ | Daily | 42.4% | 1.19 | -39.6% | 66.7% | 24 | -12.2% |
| 3 | RSI Trend (>50) ✓ | Daily | 43.2% | 1.13 | -48.3% | 43.0% | 107 | -11.4% |
| 4 | EMA 20/50 Cross ✓ | Daily | 49.5% | 1.21 | -48.5% | 57.1% | 14 | -5.1% |
| 5 | Donchian Midline ✓ | Daily | 41.8% | 1.12 | -41.9% | 42.7% | 110 | -12.9% |
| 6 | Rate of Change ✓ | Daily | 42.5% | 1.11 | -44.7% | 45.7% | 129 | -12.1% |
| 7 | EMA-10 Trend ✓ | Weekly | 42.3% | 1.1 | -45.0% | 60.6% | 33 | -11.8% |
| 8 | MACD ✓ | Weekly | 48.2% | 1.15 | -29.4% | 78.6% | 14 | -5.9% |
| 9 | RSI Trend (>50) ✓ | Weekly | 49.1% | 1.2 | -45.7% | 53.8% | 13 | -5.0% |
| 10 | Rate of Change ✓ | Weekly | 37.8% | 1.01 | -51.6% | 47.6% | 21 | -16.3% |
| 11 | ADX / DMI ✓ | Daily | 31.1% | 0.99 | -40.5% | 48.1% | 54 | -23.5% |
| 12 | Bollinger Breakout ✓ | Daily | 28.1% | 0.98 | -33.2% | 53.7% | 41 | -26.5% |
| 13 | EMA-10 Trend ✓ | Daily | 33.2% | 0.94 | -51.8% | 43.4% | 189 | -21.4% |
| 14 | Bollinger Mean-Reversion ✓ | Daily | 26.7% | 0.92 | -53.0% | 78.8% | 33 | -27.9% |
✓ = held up out-of-sample. Hypothetical, costs included. See methodology.
For Vertiv (VRT), Donchian Midline on the weekly timeframe gave the best balance of return and risk in our test. It beat buy-and-hold — but remember: this is a hypothetical backtest of a standard rule, not a recommendation. Markets change. See the methodology and disclaimer.
More stock
Get the weekly edge report
The best-performing indicator per asset, what changed this week, and the honest caveats — straight to your inbox.